Filing Details
- Accession Number:
- 0001600620-24-000013
- Form Type:
- 4/A
- Zero Holdings:
- No
- Publication Time:
- 2024-02-22 16:15:26
- Reporting Period:
- 2023-03-02
- Accepted Time:
- 2024-02-22 16:15:26
- Original Submission Date:
- 2023-03-06
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1600620 | Aurinia Pharmaceuticals Inc. | AUPH | () | 4/A |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1363683 | Peter Greenleaf | #140, 14315-118 Avenue Edmonton A0 T5L 4S6 | Chief Executive Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2023-03-02 | 33,047 | $8.78 | 982,671 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- Represents the number of shares automatically sold to cover tax withholding obligations in connection with the vesting of RSUs.
Billionaire Hedge Funds
